MOTS-c
Mitochondrial-derived peptide
A 16-residue peptide encoded in mitochondrial DNA rather than the nuclear genome — one of a small class of mitochondrial-derived peptides.
Current lot verified
CP-MOTSC-2607A · tested Jul 24, 2026
99.89 %
HPLC purity
About MOTS-c
MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial 12S rRNA gene. Its existence is conceptually notable: mitochondrial DNA was long assumed to encode only the respiratory chain subunits and the RNA machinery to translate them, and the mitochondrial-derived peptide class demonstrates that the mitochondrial genome also produces signalling molecules that act on the nucleus. MOTS-c has been shown to translocate to the nucleus under metabolic stress and regulate nuclear gene expression, which puts it in an unusual retrograde-signalling category.
The published mechanistic work involves the folate-methionine cycle, AICAR accumulation and downstream AMPK activation, with research interest in insulin sensitivity and exercise-mimetic phenotypes. It is a straightforward peptide to synthesise and handle; the interest is in what it does, not in getting it into solution.
Published research areas
- Mitochondrial retrograde signalling
- AMPK pathway activation
- Insulin sensitivity models
- Exercise mimetic research
Specifications
- CAS number
- 1627580-64-6
- Molecular formula
- C101H152N28O22S2
- Molecular weight
- 2174.60 g/mol
- Release specification
- ≥ 98.0 % by HPLC
- Appearance
- White lyophilised powder
- Solubility
- Soluble in water
- Storage
- -20 °C lyophilised, protected from light
- Format
- lyophilized vial
Sequence
H-Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg-OH
Handling and reconstitution
Two methionine residues make this sequence oxidation-prone. Minimise headspace air on stored stock.
Storage: -20 °C lyophilised, protected from light
Full reconstitution and storage referenceLot history
Every released lot of this compound, oldest kept on file. Average across 2 lots: 99.32 %.
| Lot | Strength | Purity | Tested | Laboratory | |
|---|---|---|---|---|---|
| CP-MOTSC-2607A | 10 mg | 99.89 % | Jul 24, 2026 | Janoshik Analytical | Certificate → |
| CP-MOTSC-2605B | 20 mg | 98.75 % | May 21, 2026 | Colmaric Analyticals | Certificate → |
Others in Longevity & Cellular
Longevity & Cellular
SS-31
Elamipretide, cardiolipin-targeting tetrapeptide
From
$95



